What do systematic reviews say?

Corticosteroids vs placebo

Corticosteroids may leads to lower vomiting ‐ postoperative compared with placebo (low certainty).

• Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section 2021 · Cochrane Headline outcomes only
  RR 0.68 [0.49, 0.95]
  7 studies · 793 participants
  Low

Anticholinergic medication vs placebo

Anticholinergics may leads to lower nausea ‐ intraoperative compared with placebo (low certainty).

• Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section 2021 · Cochrane Headline outcomes only
  RR 0.67 [0.51, 0.87]
  4 studies · 453 participants
  Low
• Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section 2021 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

Anticholinergic medication vs placebo

It is very uncertain whether anticholinergics changes vomiting ‐ intraoperative compared with placebo (very low certainty).

• Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section 2021 · Cochrane Headline outcomes only
  RR 0.79 [0.4, 1.54]
  4 studies · 453 participants
  Very low

5‐HT3 antagonists vs placebo

It is very uncertain whether 5‐HT3 antagonists changes vomiting ‐ intraoperative compared with placebo (very low certainty).

• Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section 2021 · Cochrane Headline outcomes only
  RR 0.46 [0.29, 0.73]
  11 studies · 1414 participants
  Very low

Anticholinergic medication vs placebo

Anticholinergics may leads to lower vomiting ‐ postoperative compared with placebo (low certainty).

• Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section 2021 · Cochrane Headline outcomes only
  RR 0.55 [0.41, 0.74]
  1 study · 161 participants
  Low

Sedation vs placebo

Sedatives probably leads to lower nausea ‐ intraoperative compared with placebo (moderate certainty).

• Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section 2021 · Cochrane Headline outcomes only
  RR 0.65 [0.51, 0.82]
  8 studies · 593 participants
  Moderate
• Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section 2021 · Cochrane Headline outcomes only
  RR 0.25 [0.09, 0.71]
  2 studies · 145 participants
  Very low

Sedation vs placebo

Sedatives probably leads to lower vomiting ‐ intraoperative compared with placebo (moderate certainty).

• Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section 2021 · Cochrane Headline outcomes only
  RR 0.35 [0.24, 0.52]
  8 studies · 593 participants
  Moderate

Sedation vs placebo

Sedatives may leads to lower vomiting ‐ postoperative compared with placebo (low certainty).

• Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section 2021 · Cochrane Headline outcomes only
  RR 0.09 [0.03, 0.28]
  2 studies · 145 participants
  Low

5‐HT3 antagonists vs placebo

5‐HT3 antagonists may leads to lower vomiting ‐ postoperative compared with placebo (low certainty).

• Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section 2021 · Cochrane Headline outcomes only
  RR 0.47 [0.31, 0.69]
  10 studies · 1450 participants
  Low

Dopamine antagonists vs placebo

It is very uncertain whether dopamine antagonists changes nausea ‐ intraoperative compared with placebo (very low certainty).

• Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section 2021 · Cochrane Headline outcomes only
  RR 0.38 [0.27, 0.52]
  15 studies · 1180 participants
  Very low
• Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section 2021 · Cochrane Headline outcomes only
  RR 0.61 [0.48, 0.79]
  7 studies · 601 participants
  Low

Dopamine antagonists vs placebo

Dopamine antagonists may leads to lower vomiting ‐ intraoperative compared with placebo (low certainty).

• Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section 2021 · Cochrane Headline outcomes only
  RR 0.41 [0.28, 0.6]
  12 studies · 942 participants
  Low

Dopamine antagonists vs placebo

It is very uncertain whether dopamine antagonists changes vomiting ‐ postoperative compared with placebo (very low certainty).

• Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section 2021 · Cochrane Headline outcomes only
  RR 0.63 [0.44, 0.92]
  9 studies · 860 participants
  Very low

Antistaphylococcal cephalosporins C1 and C2 (1st and 2nd generation) vs broad spectrum penicillins plus betalactamase inhibitors P2+ ‐ all outcomes

It is very uncertain whether antistaphylococcal cephalosporins C1 and C2 (1st and 2nd generation) changes maternal sepsis compared with broad spectrum penicillins plus betalactamase inhibitors P2+ ‐ all… (very low certainty).

• Different classes of antibiotics given to women routinely for preventing infection at caesarean section 2021 · Cochrane Headline outcomes only
  RR 2.37 [0.1, 56.41]
  1 study · 75 participants
  Very low

Antistaphylococcal cephalosporins C1 and C2 (1st and 2nd generation) vs broad spectrum penicillins plus betalactamase inhibitors P2+ ‐ all outcomes

Antistaphylococcal cephalosporins C1 and C2 (1st and 2nd generation) showed no clear difference in maternal endometritis compared with broad spectrum penicillins plus betalactamase inhibitors P2+ ‐ all… (low certainty).

• Different classes of antibiotics given to women routinely for preventing infection at caesarean section 2021 · Cochrane Headline outcomes only
  RR 1.1 [0.76, 1.6]
  7 studies · 1161 participants
  Low

Antistaphylococcal cephalosporins C1 and C2 (1st and 2nd generation) vs broad spectrum penicillins plus betalactamase inhibitors P2+ ‐ all outcomes

• Different classes of antibiotics given to women routinely for preventing infection at caesarean section 2021 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

Antistaphylococcal cephalosporins C1 and C2 (1st and 2nd generation) vs broad spectrum penicillins plus betalactamase inhibitors P2+ ‐ all outcomes

• Different classes of antibiotics given to women routinely for preventing infection at caesarean section 2021 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

Antistaphylococcal cephalosporins C1 and C2 (1st and 2nd generation) vs broad spectrum penicillins plus betalactamase inhibitors P2+ ‐ all outcomes

It is very uncertain whether antistaphylococcal cephalosporins C1 and C2 (1st and 2nd generation) changes maternal wound infection compared with broad spectrum penicillins plus betalactamase inhibitors P2+ ‐ all… (very low certainty).

• Different classes of antibiotics given to women routinely for preventing infection at caesarean section 2021 · Cochrane Headline outcomes only
  RR 0.78 [0.32, 1.9]
  4 studies · 543 participants
  Very low

Antistaphylococcal cephalosporins C1 and C2 (1st and 2nd generation) vs broad spectrum penicillins plus betalactamase inhibitors P2+ ‐ all outcomes

It is very uncertain whether antistaphylococcal cephalosporins C1 and C2 (1st and 2nd generation) changes maternal urinary tract infection compared with broad spectrum penicillins plus betalactamase inhibitors P2+ ‐ all… (very low certainty).

• Different classes of antibiotics given to women routinely for preventing infection at caesarean section 2021 · Cochrane Headline outcomes only
  RR 0.64 [0.11, 3.73]
  4 studies · 496 participants
  Very low

Antistaphylococcal cephalosporins C1 and C2 (1st and 2nd generation) vs broad spectrum penicillins plus betalactamase inhibitors P2+ ‐ all outcomes

It is very uncertain whether antistaphylococcal cephalosporins C1 and C2 (1st and 2nd generation) changes maternal composite adverse effects compared with broad spectrum penicillins plus betalactamase inhibitors P2+ ‐ all… (very low certainty).

• Different classes of antibiotics given to women routinely for preventing infection at caesarean section 2021 · Cochrane Headline outcomes only
  RR 0.96 [0.09, 10.5]
  2 studies · 468 participants
  Very low

Intervention not reported

• Ultrasound for diagnosis of birth weight discordance in twin pregnancies 2021 · Cochrane Headline outcomes only
  no estimate extracted
  22 studies · 1462 participants
  Very low